HNP Capital’s Bristol-Myers Squibb BMY Stock Holding History

HNP Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$977K	Sell	14,094 -16	-0.1%	-$1.13K	0.27%	76
2022 Q4	$1.02M	Buy	14,110 +46	+0.3%	+$3.47K	0.28%	76
2022 Q3	$1M	Sell	14,064 -1,176	-8%	-$85.3K	0.29%	76
2022 Q2	$1.17M	Buy	15,240 +994	+7%	+$75.7K	0.32%	78
2022 Q1	$1.04M	Hold	14,246	–	–	0.25%	84
2021 Q4	$888K	Hold	14,246	–	–	0.2%	93
2021 Q3	$843K	Hold	14,246	–	–	0.21%	91
2021 Q2	$952K	Hold	14,246	–	–	0.25%	87
2021 Q1	$899K	Hold	14,246	–	–	0.27%	82
2020 Q4	$884K	Buy	14,246 +780	+6%	+$48K	0.29%	75
2020 Q3	$859K	Sell	13,466 -510	-4%	-$30.7K	0.31%	73
2020 Q2	$827K	Sell	13,976 -27,118	-66%	-$1.62M	0.34%	65
2020 Q1	$2.49M	Buy	41,094 +27,528	+203%	+$1.68M	0.37%	65
2019 Q4	$885K	Buy	13,566 +450	+3%	+$25.8K	0.38%	60
2019 Q3	$650K	Sell	13,116 -760	-5%	-$35.7K	0.36%	57
2019 Q2	$629K	Sell	13,876 -15	-0.1%	-$699	0.37%	57
2019 Q1	$663K	Sell	13,891 -98	-0.7%	-$4.88K	0.41%	55
2018 Q4	$727K	Buy	+13,989	New	+$752K	0.49%	47

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HNP Capital's BMY Position: Q1 2023 in Review

HNP Capital reduced its Bristol-Myers Squibb (BMY) stake by 0.11% in Q1 2023, selling an estimated $1.13K and leaving 14,094 shares worth $977K. The position accounts for 0.27% of the portfolio, ranked #76.

HNP Capital first reported a position in BMY in Q4 2018 and has held it in 18 quarters since. The position peaked at $2.49M in Q1 2020. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

HNP Capital held 14,094 shares of Bristol-Myers Squibb worth $977K as of Q1 2023.
HNP Capital sold 16 Bristol-Myers Squibb shares in Q1 2023, an estimated $1.13K.
Bristol-Myers Squibb made up 0.27% of HNP Capital's portfolio in Q1 2023, its #76 holding.
HNP Capital first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 18 quarters since.
HNP Capital's Bristol-Myers Squibb position peaked at $2.49M in Q1 2020.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.